GuanfacineExtended-Release (TWi Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Guanfacine drug offered from TWi Pharmaceuticals, Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: TWi Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Guanfacine
SUBSTANCE NAME: GUANFACINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00


Guanfacine Extended-Release HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGuanfacine Extended-Release from TWi Pharmaceuticals, Inc.
LABELER NAME: TWi Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/1)
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24979-533_60fbfa61-0e7c-4064-b475-31f23064261d
PRODUCT NDC: 24979-533
APPLICATION NUMBER: ANDA201408

Other GUANFACINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalGuanfacine
Golden State Medical Supply, Inc.Guanfacine
Par Pharmaceutical Inc.Guanfacine
TWi Pharmaceuticals, Inc.Guanfacine